Lopez, Ronnie D.
HRN: 21-88-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/09/2022
09/16/2022
500MG
IV
Q8h
Acute Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes